GL1X · GenesisL1 explorer

Research workbench

Crystal form 1 of ALPHA1-antichymotrypsin variant dbs-II-allo: an allosterically modulated drug-binding serpin for doxorubicin

Analyse Crystal form 1 of ALPHA1-antichymotrypsin variant dbs-II-allo: an… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6FTP
Type
protein
Length
369 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-1-antichymotrypsin
UniProt
P01011
Ligands
DM2
Pockets
3 · best druggability 0.54

Structure

x-ray diffraction · 2 distinct chains · 31% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha-1-antichymotrypsinprotein33534% helix, 36% strandP01011
BAlpha-1-antichymotrypsinprotein340% helix, 50% strandP01011

Ligands and binding sites

  • DM2 · Doxorubicin · ligand · chains A, B
  • EDO · 1,2-ethanediol · additive · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1520.540.8921EDO
21000.450.7915DM2
3800.380.7818empty

Interfaces

1 interface between chains.

  • A–B · 2421 Ų buried · 37 hydrogen bonds · protein-protein

Compared structures

  • 6FTP · Crystal form 1 of Alpha1-antichymotrypsin variant DBS-II-allo: an allosterically… · the same entry in another collection · chain A against A, TM-score 1.00
  • P01011 · AlphaFold monomer V2.0 prediction for alpha-1-antichymotrypsin (P01011) · a predicted model of the same protein · chain A against A, TM-score 0.93

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.